New hybrid furoxan structures with antiaggregant activity

Larin A.A., Fershtat L.L., Ustyuzhanina N.E., Gening M.L., Nifantiev N.E., Makhova N.N.
Тип документаJournal Article
Дата публикации2018-11-01
Название журналаMendeleev Communications
ИздательElsevier
КвартильQ2
ISSN09599436, 1364551X
  • General Chemistry
Краткое описание
A series of functionalized furoxans was synthesized, and their effect on the platelet aggregation was estimated using a set of inducers. New hybrid structures comprising the furoxan ring and glycolic or acetylsalicylic acid motifs effectively inhibit aggregate formation induced by adenosine diphosphate and adrenaline. Studies of their NO-donor ability showed that their antiplatelet effects were mainly independent of the NO action.
Пристатейные ссылки: 27
Цитируется в публикациях: 12
Antiaggregant activity of water-soluble furoxans
Ustyuzhanina N.E., Fershtat L.L., Gening M.L., Nifantiev N.E., Makhova N.N.
Q2 Mendeleev Communications 2018 цитирований: 18
Recent advances in synthesis of organic nitrogen–oxygen systems for medicine and materials science
Zlotin S.G., Churakov A.M., Dalinger I.L., Luk’yanov O.A., Makhova N.N., Sukhorukov A.Y., Tartakovsky V.A.
Q2 Mendeleev Communications 2017 цитирований: 35
Classical and interdisciplinary approaches to the design of organic and hybrid molecular systems
Vereshchagin A.N.
Q3 Russian Chemical Bulletin 2017 цитирований: 23
Organic and hybrid systems: from science to practice
Ananikov V.P., Eremin D.B., Yakukhnov S.A., Dilman A.D., Levin V.V., Egorov M.P., Karlov S.S., Kustov L.M., Tarasov A.L., Greish A.A., Shesterkina A.A., Sakharov A.M., Nysenko Z.N., Sheremetev A.B., Stakheev A.Y., et. al.
Q2 Mendeleev Communications 2017 цитирований: 76
Synthesis, structural characterization and cytotoxic activity of heterocyclic compounds containing the furoxan ring
Kulikov A.S., Larin A.A., Fershtat L.L., Anikina L.V., Pukhov S.A., Klochkov S.G., Struchkova M.I., Romanova A.A., Ananyev I.V., Makhova N.N.
Q4 Arkivoc 2017 цитирований: 17
Open Access
Open access
Furoxans fused with heterocycles as promising donors and precursors for nitric oxide donors (microreview)
Makhova N.N., Rakitin O.A.
Q3 Chemistry of Heterocyclic Compounds 2017 цитирований: 9
Molecular Hybridization Tools in the Development of Furoxan-Based NO-Donor Prodrugs
Fershtat L.L., Makhova N.N.
Q1 ChemMedChem 2017 цитирований: 45
New insight into the antiaggregant activity of furoxans
Ustyuzhanina N.E., Fershtat L.L., Gening M.L., Nifantiev N.E., Makhova N.N.
Q2 Mendeleev Communications 2016 цитирований: 21
Challenges in the development of organic and hybrid molecular systems
Ananikov V.P., Galkin K.I., Egorov M.P., Sakharov A.M., Zlotin S.G., Redina E.A., Isaeva V.I., Kustov L.M., Gening M.L., Nifantiev N.E.
Q2 Mendeleev Communications 2016 цитирований: 86
Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events
Rosseto L., Pires M., Melchior A., Bosquesi P., Pavan A., Marcondes S., Chung M., Santos J.
Q2 Molecules 2015 цитирований: 9
Open Access
Open access
Novel amino acids: synthesis of furoxan and sydnonimine containing amino acids and peptides as potential nitric oxide releasing motifs
Nortcliffe A., Botting N.P., O'Hagan D.
Q1 Organic and Biomolecular Chemistry 2013 цитирований: 24
Role of Platelets and Antiplatelet Therapy in Cardiovascular Disease
Ueno M., Kodali M., Tello-Montoliu A., Angiolillo D.J.
Q1 Journal of Atherosclerosis and Thrombosis 2011 цитирований: 32
Open Access
Open access
Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy
Warner T.D., Nylander S., Whatling C.
Q1 British Journal of Clinical Pharmacology 2011 цитирований: 121
Studies of the potential genotoxic effects of furoxans: The case of CAS 1609 and of the water-soluble analogue of CHF 2363
Balbo S., Lazzarato L., Di Stilo A., Fruttero R., Lombaert N., Kirsch-Volders M.
Q1 Toxicology Letters 2008 цитирований: 14
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities
Del Grosso E., Boschi D., Lazzarato L., Cena C., Di Stilo A., Fruttero R., Moro S., Gasco A.
Q3 Chemistry and Biodiversity 2005 цитирований: 26
Метрики
Поделиться
Цитировать
ГОСТ |
Цитировать
1. Larin A.A. и др. New hybrid furoxan structures with antiaggregant activity // Mendeleev Communications. 2018. Т. 28. № 6. С. 595–597.
RIS |
Цитировать

TY - JOUR

DO - 10.1016/j.mencom.2018.11.010

UR - http://dx.doi.org/10.1016/j.mencom.2018.11.010

TI - New hybrid furoxan structures with antiaggregant activity

T2 - Mendeleev Communications

AU - Larin, Alexander A.

AU - Fershtat, Leonid L.

AU - Ustyuzhanina, Nadezhda E.

AU - Gening, Marina L.

AU - Nifantiev, Nikolay E.

AU - Makhova, Nina N.

PY - 2018

DA - 2018/11

PB - Elsevier BV

SP - 595-597

IS - 6

VL - 28

SN - 0959-9436

ER -

BibTex |
Цитировать

@article{2018,

doi = {10.1016/j.mencom.2018.11.010},

url = {https://doi.org/10.1016%2Fj.mencom.2018.11.010},

year = 2018,

month = {nov},

publisher = {Elsevier {BV}},

volume = {28},

number = {6},

pages = {595--597},

author = {Alexander A. Larin and Leonid L. Fershtat and Nadezhda E. Ustyuzhanina and Marina L. Gening and Nikolay E. Nifantiev and Nina N. Makhova},

title = {New hybrid furoxan structures with antiaggregant activity}

}

MLA
Цитировать
Larin, Alexander A. et al. “New Hybrid Furoxan Structures with Antiaggregant Activity.” Mendeleev Communications 28.6 (2018): 595–597. Crossref. Web.